Schrödinger, Inc. (NASDAQ:SDGR) Receives Consensus Recommendation of "Buy" from Analysts

Shares of Schrödinger, Inc. (NASDAQ:SDGR - Get Free Report) have earned a consensus rating of "Buy" from the six brokerages that are presently covering the firm, MarketBeat reports. One analyst has rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the company. The average twelve-month price target among analysts that have issued ratings on the stock in the last year is $32.80.

Several analysts have recently weighed in on SDGR shares. Piper Sandler decreased their target price on shares of Schrödinger from $50.00 to $45.00 and set an "overweight" rating on the stock in a research report on Thursday, February 27th. KeyCorp upped their price objective on Schrödinger from $30.00 to $32.00 and gave the company an "overweight" rating in a research note on Wednesday, April 16th.

Schrödinger Stock Down 6.1%

NASDAQ SDGR traded down $1.40 during trading on Tuesday, hitting $21.43. The company's stock had a trading volume of 1,726,041 shares, compared to its average volume of 896,069. Schrödinger has a 52 week low of $16.60 and a 52 week high of $28.47. The firm has a market cap of $1.57 billion, a P/E ratio of -9.16 and a beta of 1.63. The firm has a 50 day moving average price of $23.57 and a 200 day moving average price of $22.41.

Schrödinger (NASDAQ:SDGR - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The company reported ($0.82) earnings per share for the quarter, missing analysts' consensus estimates of ($0.81) by ($0.01). The company had revenue of $59.55 million during the quarter, compared to the consensus estimate of $54.60 million. Schrödinger had a negative net margin of 91.84% and a negative return on equity of 35.77%. Schrödinger's revenue for the quarter was up 62.7% on a year-over-year basis. During the same period last year, the company earned ($0.86) earnings per share. On average, equities analysts expect that Schrödinger will post -2.37 earnings per share for the current year.

Insider Activity

In other Schrödinger news, insider Karen Akinsanya sold 16,723 shares of Schrödinger stock in a transaction on Monday, April 14th. The stock was sold at an average price of $25.09, for a total value of $419,580.07. Following the completion of the transaction, the insider now owns 15,625 shares in the company, valued at approximately $392,031.25. The trade was a 51.70% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 8.60% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the business. Geneos Wealth Management Inc. increased its position in Schrödinger by 41.6% in the 1st quarter. Geneos Wealth Management Inc. now owns 84,943 shares of the company's stock valued at $1,677,000 after acquiring an additional 24,947 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in shares of Schrödinger by 169.0% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 4,357,532 shares of the company's stock valued at $86,018,000 after purchasing an additional 2,737,728 shares in the last quarter. Jones Financial Companies Lllp raised its position in Schrödinger by 34,925.9% in the 1st quarter. Jones Financial Companies Lllp now owns 216,110 shares of the company's stock worth $4,266,000 after purchasing an additional 215,493 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in Schrödinger by 4.5% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 33,055 shares of the company's stock worth $653,000 after buying an additional 1,412 shares in the last quarter. Finally, Kodai Capital Management LP bought a new position in Schrödinger in the 1st quarter valued at $3,026,000. 79.05% of the stock is owned by institutional investors.

Schrödinger Company Profile

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.